Home

PharmaEngine, Inc. (4162)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about PharmaEngine, Inc. (4162)

Go deeper and ask any question about 4162

Company Performance

Current Price

as of Sep 16, 2024

$2.59

P/E Ratio

33.11

Market Cap

$370.3M

Description

PharmaEngine, Inc. engages in the research, development and manufacture of biopharmaceutical products. It develops drug treatments for pancreatic, gastric, brain, breast, head, neck, liver, rectal and prostate cancer; soft tissue sarcoma, and solid tumor. The company was founded by Chang Ching Yeh and Jung Chin Lin on August 12, 2002 and is headquartered in Taipei, Taiwan.

Metrics

Overview

  • HQTaipei, TP
  • SectorHealth Technology
  • IndustryPharmaceuticals: Major
  • Ticker4162
  • Price$2.594112+0.83%

Trading Information

  • Market Cap$370.30M
  • Float82.02%
  • Average Daily Volume (1m)259,888
  • Average Daily Volume (3m)635,442
  • EPS$2.50

Company

  • Revenue$859.64M
  • Rev Growth (1yr)57.71%
  • Net Income$158.87M
  • Gross Margin95.59%
  • EBITDA Margin55.75%
  • EBITDA$146.01M
  • EV$10.14B
  • EV/Revenue11.80
  • P/E33.11
  • P/S13.82
Documents